Related content

Controlled ovarian hyperstimulation: Does prolonged stimulation justify cancellation of in vitro fertilization cycles?

By Bar-Hava Itat   Yoeli Rakefet   Yulzari-Roll Vered   Ashkenazi Jacob   Shalev Josef   Orvieto Raoul  

Gynecological Endocrinology, Vol. 21, Iss. 4, 2005-10 ,pp. : 232-234

Informa Healthcare

Access to resources Recommend Favorite

Does day-3 LH/FSH ratio influence in vitro fertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue?

By Orvieto Raoul   Meltcer Simion   Liberty Gad   Rabinson Jacob   Anteby Eyal Y.   Nahum Ravit  

Gynecological Endocrinology, Vol. 28, Iss. 6, 2012-06 ,pp. : 422-424

Informa Healthcare

Access to resources Recommend Favorite

Inclusion of standard and low-dose gonadotropin releasing hormone-analog (short protocol) in controlled ovarian hyperstimulation regimens in normogonadotropic patients aged 40-48 years who are undergoing in vitro fertilization

By Avrech OM   Orvieto R   Pinkas H   Sapir-Rufas O   Feldberg D   Fisch B  

Gynecological Endocrinology, Vol. 19, Iss. 5, 2004-11 ,pp. : 247-252

Informa Healthcare

Access to resources Recommend Favorite

Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles

By Bosch E.   Labarta E.   Crespo J.   Simn C.   Remoh J.   Jenkins J.   Pellicer A.  

Human Reproduction, Vol. 25, Iss. 8, 2010-08 ,pp. : 2092-2100

Oxford University Press

Access to resources Recommend Favorite

Effect of endometriosis on the protein expression pattern of follicular fluid from patients submitted to controlled ovarian hyperstimulation for in vitro fertilization

By Lo Turco Edson Guimaraes   Souza Gustavo Henrique Martins Ferreira   Garcia Jerusa Simone   Ferreira Christina Ramires   Eberlin Marcos Nogueira   Bertolla Ricardo Pimenta  

Human Reproduction, Vol. 25, Iss. 7, 2010-07 ,pp. : 1755-1766

Oxford University Press

Access to resources Recommend Favorite